AspenBio Pharma Commences FDA Clinical Trial For AppyScoreTM Appendicitis Blood Test
Jun 30th 2008Drug InformationBlood
AspenBio Pharma, Inc. (NASDAQ: APPY) an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, has officially initiated a clinical trial to support the FDA 510(k) application for the AppyScore? Human Appendicitis blood-based diagnostic test. Enrollment of the first patients in the independent, blind, multicenter study began this week, which will include patients from a large children’s hospital.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
